7000 Corsica Dr.
Germantown, Tennessee 38138
901-603-3817

Research
Overview

NeuroDyne Inc. has developed a new technology that addresses the unmet medical need of neurological disorders.

Epilepsy is a neurological disorder which affects more than 70 million people worldwide. There are more than 3 million epilepsy patients in the U.S. alone, with 100,000 new cases reported every year. Annual direct medical cost translates to billions, while indirect costs are much more due to the loss of lifetime earnings estimating at 35% for men and 25% for women. Social alienation often causes epilepsy patients to develop other neurological disorders like clinical depression and psychosis.

Most types of epilepsy treatments involve the prescription of anti-epileptic drugs (AEDs) that help control seizures in 70% of epileptic patients. However, AEDs remain complicated by short and long term side effects. Alternatives include epilepsy surgery which offers a 50–65% probability of relief from disabling seizures, but is possible in only 8% of chronic epilepsy patients. Another alternative, vagus nerve stimulation (VNS), offers only palliative treatment.

Healthcare Professionals
Innovation of Technology

NeuroDyne Inc. has discovered a major advancement in diagnosis and treatment of brain trauma conditions due to trauma or stroke with a new technology called High Definition tDCS (HD-tDCS). This device can be utilized for lessening the following:

  • Depression
  • Migraines
  • Pain
  • Anxiety
  • Increase Memory Performance
  • Cumulative Motor Movement
Our system provides a clear improvement over the convention rehabilitation. Our research in neuro-diseases has focused on intractable seizures, i.e. seizures that cannot be cured through medicine or surgery, Parkinson’s, migraines, and ‘smart-prosthetics’, which has enabled patients to control their prosthetic via their brain signals just like they were controlling their arms and legs before there trauma occurred. We have developed a new way to help those that cannot receive help from conventional means, within a shortened amount of time, to increase the quality of life.

Latest News

  • Intel Finalist 2013

    Akshay Padmanabha of Collierville, Tenn., placed ninth in the Intel Science Talent Search, the nation’s most prestigious science and math competition for high school seniors.
  • Dr. Mark H. Myers speaks at IJCNN 2011

    The International Joint Conference on Neural Networks is the premier international conference in the area of neural networks.
  • Clinical evidence that this technology works

    The data, in a 10 patient analysis, demonstrated the system was 86% accurate in detecting seizures.